Combined procedure for PEXG and cataract

Article

Combined phacoemulsification and viscocanalostomy achieves excellent intraocular pressure (IOP) control and improves visual acuity (VA) in patients with co-existing cataract and pseudoexfoliation glaucoma (PEXG).

Combined phacoemulsification and viscocanalostomy achieves excellent intraocular pressure (IOP) control and improves visual acuity (VA) in patients with co-existing cataract and pseudoexfoliation glaucoma (PEXG), according to Mohammed Awadalla and colleagues from Saudi Arabia.

A prospective, non-comparative study of 30 consecutive eyes with uncontrolled PEXG associated with cataract was conducted. Each subject received the combined phacoemulsification and viscocanalostomy procedure. Postoperative follow-up ranged from between 12 and 24 months.

At the final follow-up, IOP was reduced by more 30% with only five eyes (16.6%) requiring a single anti-glaucoma medication to achieve target IOP. The mean preoperative best spectacle corrected visual acuity (BSCVA) was 0.16, whilst mean postoperative uncorrected vision and BSCVA were 0.5 and 0.7, respectively. Complication rates were low and did not affect the surgical outcome.

The results of this study reveal that combined phacoemulsification and viscocanalostomy can achieve excellent results in both IOP control and visual acuity.

Recent Videos
Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
Carl J. Danzig, MD
Martin Zinkernagel, MD, PhD, speaks about the ASRS sustainability expert panel
Srinivas Sai Kondapalli, MD, discusses outer retinal tubulations in lesion growth for subfoveal and non-subfoveal GA
Jennifer I. Lim, MD, FARVO, FASRS
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
© 2024 MJH Life Sciences

All rights reserved.